Thrombosis Research
Volume 126, Issue 3 , Pages e225-e231 , September 2010

Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia

  • Sara Tehrani

      Affiliations

    • Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Division of Internal Medicine, Danderyd Hospital, S-18288 Stockholm, Sweden. Tel.: +46 8 6555000; fax: +46 8 6556187.
    • ,
  • Fariborz Mobarrez

      Affiliations

    • Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden
    • ,
  • Aleksandra Antovic

      Affiliations

    • Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Stockholm, Sweden
    • ,
  • Pia Santesson

      Affiliations

    • Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Stockholm, Sweden
    • ,
  • Per-Eric Lins

      Affiliations

    • Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Stockholm, Sweden
    • ,
  • Ulf Adamson

      Affiliations

    • Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Stockholm, Sweden
    • ,
  • Peter Henriksson

      Affiliations

    • Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden
    • ,
  • N. Håkan Wallén

      Affiliations

    • Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden
    • ,
  • Gun Jörneskog

      Affiliations

    • Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Stockholm, Sweden

Received 5 March 2010 ,Revised 25 May 2010 ,Accepted 28 May 2010.

References 

  1. Watala C, Boncler M, Gresner P. Blood platelet abnormalities and pharmacological modulation of platelet activity in patients with diabetes mellitus. Pharmacol Rep. 2005;57:42–58
  2. Ganda OP, Arkin CF. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. Diabetes Care. 1992;15:1245–1250
  3. Ceriello A, Taboga C, Giacomello R, Falleti E, De Stasio G, Motz E, et al. Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes. 1994;43:430–432
  4. Blombäck B, Carlsson K, Fatah K, Hessel B, Procyck R. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb Res. 1994;5:521–538
  5. Weisel JW. Structure of fibrin: impact on clot stability. J Thromb Haemost. 2007;5:116–124
  6. Blombäck B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Åslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta. 1989;997:96–110
  7. Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, et al. Influence on fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 2000;20:1354–1361
  8. Jörneskog G, Egberg N, Fagrell B, Fatah K, Hessel B, Johnsson H, et al. Altered properties of the fibrin gel structure in patients with IDDM. Diabetologia. 1996;39:1519–1523
  9. Jörneskog G, Hansson L, Wallen NH, Yngen M, Blombäck M. Increased plasma fibrin gel porosity in patients with type 1 diabetes during continuous subcutaneous insulin infusion. J Thromb Haemost. 2003;1:1195–1201
  10. Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009;360:1851–1861
  11. Colhoun H, Betteridge JD, Durington PN, Hitman GA, Neil AW, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685–696
  12. Collins R, Armitage J, Parish S, Sleight P, Peto R Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with Simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;9374:2005–2016
  13. Undas A, Brummel-Ziedins K, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol. 2005;2:287–294
  14. Notarbartolo A, Davì G, Averna M, Barbagallo CM, Ganci A, Giammarresi C, et al. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1995;15:247–251
  15. Yngen M, Östenson CG, Hu H, Li N, Hjemdahl P, Wallén NH. Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia. 2004;47:537–540
  16. Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood. 1996;87:4651–4663
  17. Sommeijer DW, Joop K, Leyte A, Reitsma PH, ten Cate H. Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes. J Thromb Haemost. 2005;3:1168–1171
  18. Mobarrez F, Antovic J, Egberg N, Hansson M, Jörneskog G, Hultenby K, et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res. 2010 Mar;125:e110–e116
  19. He S, Cao H, Antovic A, Blombäck M. Modifications in flow measurement of fibrin gel permeability: a possible tool for determining the fibrinolytic potential in clinical materials. Blood Coagul Fibrinolys. 2005;16:61–67
  20. Blombäck B, Okada M. Fibrin gel structure and clotting time. Thromb Res. 1982;25:51–70
  21. Hemker HC. Al Dieri R, De Smedt E, Béguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. J Thromb Haemost. 2006;5:553–561
  22. Undas A, Celinska-Löwenhoff M, Löwenhoff T, Szczeklik A. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary heart disease. J Thromb Haemost. 2005;4:1029–1036
  23. Bröijersén A, Hamsten A, Silveira A, Fatah K, Goodall AH, Eriksson M, et al. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII. J Thromb Haemost. 1996;76:171–176
  24. Wirtz PH, Ehlert U, Emini L, Rüdisüli K, Groessbauer S, Gaab J, et al. Anticipatory cognitive stress appraisal and the acute procoagulant stress response in men. Psychosom Med. 2006;6:851–858
  25. Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T, et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 1995;116:235–240
  26. Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost. 2005;31:381–392
  27. Panes O, Matus V, Sáez CG, Quiroga T, Pereira J, Mezzano D. Human platelets synthesize and express functional tissue factor. Blood. 2007;109:5242–5250
  28. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med. 2006;11:2433–2440
  29. Butenas S, Bouchard BA, Brummel-Ziedins KE, Seren-Parhami B, Mann KG. Tissue factor activity in whole blood. Blood. 2005;105:2764–2770
  30. Osterud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost. 2006;1:11–23
  31. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood. 2000;96:170–175
  32. Santos MT, Fuset MP, Ruano M, Moscardó A, Valles J. Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction. Am J Cardiol. 2009;104:1618–1623
  33. Lijnen P, Echevaría-Vázquez D, Petrov V. Influence of cholesterol-lowering on plasma membrane lipids and function. Methods Find Exp Clin Pharmacol. 1996;18:123–136
  34. Sang Kim-Hanh Le Quan, Levenson Jaime, Megnien Jean-Louis, Simon Alain, Devynck Marie-Aude. Platelet cytosolic Ca2+ and membrane dynamics in patients with primary hypercholesterolemia; effects of pravastatin. Arterioscler Thromb Vasc Biol. 1995;15:759–764
  35. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, et al. Accumulation of Tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin Glycoprotein Ligand 1 and platelet P-selectin. J Exp Med. 2003;197:1585–1598
  36. Chou J, Mackman N, Merrill-Skolff G, Pedersen B, Furie BC, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood. 2004;104:3190–3197
  37. Seljeflot I, Tonstad S, Hjermann I, Arnesen H. Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease. Thromb Res. 2002;105:285–290
  38. Undas A, Celinska-Löwenhoff M, Kaczor M, Musial J. New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb Haemost. 2004;91:1065–1077
  39. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207
  40. Jialal I, Miguelino E, Griffen SC, Devaraj S. Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes. J Clin Endocrinol Metab. 2007;92:3136–3140
  41. Dogra GK, Watts GF, Chan DC, Stanton K. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria. Diabet Med. 2005;22:239–242

☆ The results of this study were presented at the International Society on Thrombosis and Haemostasis in Boston, 2009-07-15.

PII: S0049-3848(10)00334-8

doi: 10.1016/j.thromres.2010.05.023

Thrombosis Research
Volume 126, Issue 3 , Pages e225-e231 , September 2010

Article Tools

* Image Usage & Resolution